Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2016, Article ID 7852648, 7 pages
http://dx.doi.org/10.1155/2016/7852648
Clinical Study

The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial

1Department of Pediatrics, St. Antonius Hospital, Nieuwegein/Utrecht, P.O. Box 2500, 3430 EM Nieuwegein, Netherlands
2Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein/Utrecht, P.O. Box 2500, 3430 EM Nieuwegein, Netherlands
3Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB Utrecht, Netherlands

Received 31 August 2016; Accepted 30 November 2016

Academic Editor: Till Hasenberg

Copyright © 2016 Marloes P. van der Aa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Oude Luttikhuis, L. Baur, H. Jansen et al., “Interventions for treating obesity in children,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001872, 2009. View at Google Scholar · View at Scopus
  2. C. C. Kamath, K. S. Vickers, A. Ehrlich et al., “Behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 12, pp. 4606–4615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Matson and R. M. Fallon, “Treatment of obesity in children and adolescents,” Journal of Pediatric Pharmacology and Therapeutics, vol. 17, no. 1, pp. 45–57, 2012. View at Google Scholar
  4. A. B. Wald and N. K. Uli, “Pharmacotherapy in pediatric obesity: current agents and future directions,” Reviews in Endocrine and Metabolic Disorders, vol. 10, no. 3, pp. 205–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Rogovik and R. D. Goldman, “Pharmacologic treatment of pediatric obesity,” Canadian Family Physician, vol. 57, no. 2, pp. 195–197, 2011. View at Google Scholar · View at Scopus
  6. M. S. McDonagh, S. Selph, A. Ozpinar, and C. Foley, “Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger,” JAMA Pediatrics, vol. 168, no. 2, pp. 178–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Wilson, S. H. Abrams, T. Aye et al., “Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up,” Archives of Pediatrics and Adolescent Medicine, vol. 164, no. 2, pp. 116–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. van der Aa, M. A. J. Elst, E. M. W. van de Garde, E. G. A. H. van Mil, C. A. J. Knibbe, and M. M. J. van der Vorst, “Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial,” Nutrition & Diabetes, vol. 6, no. 8, article e228, 2016. View at Publisher · View at Google Scholar
  9. E. A. M. Gale, “The Hawthorne studies—a fable for our times?” QJM—Monthly Journal of the Association of Physicians, vol. 97, no. 7, pp. 439–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Society of Occupational Medicine, “The Hawthorne effect,” Occupational Medicine, vol. 56, no. 3, p. 217, 2006. View at Google Scholar
  11. M. P. van der Aa, M. A. J. Elst, E. G. A. H. van Mil, C. A. J. Knibbe, and M. M. J. van der Vorst, “METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents—study protocol of a randomized controlled study,” Trials, vol. 15, article 207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Fazeli Farsani, M. P. Van Der Aa, M. M. J. Van Der Vorst, C. A. J. Knibbe, and A. De Boer, “Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches,” Diabetologia, vol. 56, no. 7, pp. 1471–1488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. K. Williams, B. Padhukasahasram, B. K. Ahmedani et al., “Differing effects of metformin on glycemic control by race-ethnicity,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 9, pp. 3160–3168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. K. Nagi and J. S. Yudkin, “Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: a study of two ethnic groups,” Diabetes Care, vol. 16, no. 4, pp. 621–629, 1993. View at Publisher · View at Google Scholar · View at Scopus